Global Public Attitudes About Clinical Research and Patient Experiences With Clinical Trials

Abstract

Stakeholders in the clinical research enterprise have become keenly interested in improving public and patient engagement in clinical trials¹ for reasons that include ensuring that the most relevant and clinically meaningful outcomes are being assessed and improving study volunteer recruitment and retention rates.² Increasing protocol design complexity during the past 2 decades has had an adverse effect on the cost and length of the drug-development process, placed undue burden on clinical research professionals administering clinical trial procedures,^3,4 and impeded the willingness of study volunteers to be screened for and remain in a study through its completion.⁴